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Abstract
Background: Vibrio parahaemolyticus is an aquatic, halophilic, Gram-negative bacterium, first
discovered in 1950 in Japan during a food-poisoning outbreak. Infections resulting from
consumption of V. parahaemolyticus have increased globally in the last 10 years leading to the
bacterium's classification as a newly emerging pathogen. In 1996 the first appearance of a pandemic
V. parahaemolyticus clone occurred, a new O3:K6 serotype strain that has now been identified
worldwide as a major cause of seafood-borne gastroenteritis.
Results: We examined the sequenced genome of V. parahaemolyticus RIMD2210633, an O3:K6
serotype strain isolated in Japan in 1996, by bioinformatic analyses to uncover genomic islands (GIs)
that may play a role in the emergence and pathogenesis of pandemic strains. We identified 7 regions
ranging in size from 10 kb to 81 kb that had the characteristics of GIs such as aberrant base
composition compared to the core genome, presence of phage-like integrases, flanked by direct
repeats and the absence of these regions from closely related species. Molecular analysis of
worldwide clinical isolates of V. parahaemolyticus recovered over the last 33 years demonstrated
that a 24 kb region named V. parahaemolyticus island-1 (VPaI-1) encompassing ORFs VP0380 to
VP0403 is only present in new O3:K6 and related strains recovered after 1995. We investigated
the presence of 3 additional regions, VPaI-4 (VP2131 to VP2144), VPaI-5 (VP2900 to VP2910) and
VPaI-6 (VPA1254 to VPA1270) by PCR assays and Southern blot analyses among the same set of
V. parahaemolyticus isolates. These 3 VPaI regions also gave similar distribution patterns amongst
the 41 strains examined.
Conclusion: The 4 VPaI regions examined may represent DNA acquired by the pandemic group
of V. parahaemolyticus isolates that increased their fitness either in the aquatic environment or in
their ability to infect humans.
Background
Vibrio parahaemolyticus is a halophilic, Gram-negative bac-
terium, first discovered in 1950 during a food poisoning
outbreak in Osaka, Japan. V. parahaemolyticus is a seafood-
borne pathogen, which is a major causative agent of gas-
troenteritis particularly in regions with high seafood con-
sumption. In Taiwan, Japan, and South East Asian
countries, V. parahaemolyticus causes over half of all food
poisoning outbreaks of bacterial origin [1]. In recent years
outbreaks of V. parahaemolyticus infection have increased
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estimated to be responsible for 5000 illnesses per year [2].
V. parahaemolyticus infections that caused gastroenteritis
up until 1996 were associated with many different sero-
types, with a predominance of O4 serogroup strains
among clinical samples in the United States [3-5]. In 1996
the first appearance of a pandemic V. parahaemolyticus
clone occurred, a new O3:K6 serotype strain that has now
been identified worldwide as a major cause of seafood-
borne gastroenteritis [2-4,6-9].
Clinical isolates of V. parahaemolyticus produce two major
virulence factors; the thermostable direct hemolysin
(TDH) encoded by tdh, and TDH-related hemolysin
encoded by trh. Several studies have demonstrated that
most pandemic V. parahaemolyticus new O3:K6 serotype
isolates contain the tdh gene but not the trh gene and are
hemolytic on Wagatsuma agar designated Kanagawa phe-
nomenon positive strains (KP+) [2,10,11]. A number of
additional biomarkers have been identified in pandemic
V. parahaemolyticus serotype O3:K6 isolates; these include
a unique toxRS sequence, a histone-like DNA-binding
protein and an open reading frame VP2905, all found to
be present exclusively in these strains [6,12-14]. The
recently emerged serotypes O4:K68, O1:KUT, O1:K25 and
O1:K41 have been shown to be clonally related to new
O3:K6 serotype strains isolated after 1995, all forming a
pandemic group [3,6,14,15]. It had been suggested that
the new O3:K6 group strains might have emerged as a
result of the transfer of genetic elements, and the V. para-
haemolyticus phage f237 is believed to be responsible for
the pandemic potential of V. parahaemolyticus [16]. How-
ever, many post-1995 V. parahaemolyticus isolates lack
phage f237 [8,17].
Genomic islands (GIs) are another group of chromo-
somal regions, which are acquired by horizontal gene
transfer that may increase fitness of the bacterium in a par-
ticular environment. For example, virulence genes present
on pathogenicity islands or genes that provide diverse
metabolic capabilities on metabolic islands can play an
important role in bacterial survival in diverse environ-
ments [18]. The DNA sequences of GIs are composition-
ally biased from their host genome in terms of G+C
content, genome signature (dinucleotide frequency) and
codon usage patterns [18]. As well as aberrant DNA com-
position, GIs have the general characteristics of encoding
a bacteriophage-like integrase, are flanked by repeat
sequences, and many GIs insert adjacent to tRNA genes
probably indicating a similar mechanism of chromo-
somal integration. GIs are usually present in a subset of
strains of a species and absent from closely related species.
From the genomic sequence of V. parahaemolyticus
RIMD2210633, an 81 kb region on chromosome 2 with a
G+C content of 39% compared to the overall G+C content
for the entire genome of 45% was identified [19]. This
potential pathogenicity island encoded a type III secretion
(TTS) system, which in other pathogenic bacteria export
bacterial proteins directly into host cells. The TTS system
on chromosome 2 was shown only to be present among
V. parahaemolyticus isolates recovered after 1995 [19].
In the present study, we interrogated the complete
genome sequence of V. parahaemolyticus strain
RIMD2210633 an O3:K6 strain clinical isolate by bioin-
formatic and molecular analyses to identify GIs that may
mark pandemic isolates. We uncovered 7 regions, ranging
in size from 10 kb to 81 kb with the characteristics of GIs.
We named these 7 regions Vibrio parahaemolyticus island-1
(VPaI-1) to VPaI-7. We examined the distribution of VPaI-
1 among a collection of 41 V. parahaemolyticus natural iso-
lates recovered between 1970 and 2003. By molecular
analyses, the VPaI-1 region was only present amongst
post-1995 serotype O3:K6 and related pandemic isolates
indicating that this region may play a role in the emer-
gence of pandemic isolates. In addition, we investigated
the distribution of VPaI-4, VPaI-5, and VPaI-6 among the
same collection of V. parahaemolyticus isolates and all 3
regions gave a similar distribution as VPaI-1 indicating
that these regions, which encoded a number of potential
virulence genes, may be involved in the emergence of pan-
demic isolates.
Results and discussion
Genomic islands (GIs) identified in V. parahaemolyticus 
RIMD2210633
We examined the whole genome sequence of V. para-
haemolyticus RIMD2210633 to identify GIs that could
potentially mark this pandemic clone. Initially we identi-
fied 9 regions of greater than 10 kb with aberrant G+C
content that encoded integrase or transposase genes.
These 9 regions included a prophage and an integron as
well as 7 additional regions, which we named V. para-
haemolyticus island-1 (VPaI-1) to VPaI-7. The 7 genomic
islands (GIs) ranged in size from 10 kb to 81 kb, were
flanked by direct repeats, and 6 of the 7 GIs had a G+C
content lower (ranging from 38% to 43%) than the over-
all genome G+C content of 45% (Table 1). All GIs
encoded an integrase gene with the exception of VPaI-7,
which contained a number of transposase genes. VPaI-7 is
an 81 kb region that encoded a TTS system and the tdh
gene and was previously identified as a potential patho-
genicity island (Table 1) [19]. Five GI regions were present
on chromosome 1 and two on chromosome 2. Four of the
GIs identified inserted adjacent to tRNA genes; VPaI-1
(tRNA-Met), VPaI-2 (tmRNA), VPaI-3 (tRNA-Ser) and
VPaI-4 (tRNA-Ser) (Table 1). Using the program devel-
oped by van Passel and co-workers, we examined the com-
positional dissimilarities among the 7 VPaI regions
identified compared to the host genome (Table 1)Page 2 of 19
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region and the V. parahaemolyticus genome sequence indi-
cates a heterologous origin of the GI. All 7 VPaI regions
that we examined had high δ* values compared to the
average for the genome of 38 for chromosome 1 and 36
for chromosome 2 (window size 10 kb) (Table 1). In
addition, we investigated the percent of genomic frag-
ments of sizes equal to each VPaI with lower δ* and
between 94 and 100 percent of genomic fragments exam-
ined had a lower δ* than the GI examined indicating that
the 7 VPaI regions uncovered had an aberrant base com-
position compared to the rest of the genome (Table 1).
Comparative analysis
Each ORF present in the 7 VPaI regions was analysed sys-
tematically by BLAST analysis to determine whether these
regions were present in sequenced members of the family
Vibrionaceae; V. vulnificus strains YJ016 and CMCP6, V.
cholerae N16961, and V. fischeri ES114. For all GIs, no
homologues were present in these sequenced genomes.
However, it was noted that four of the homologous inser-
tion sites tRNA-Met, tmRNA, and two tRNA-Ser loci, did
contain unique DNA in each of the four Vibrio genome
sequences examined. At the tRNA-Met locus (genome
location 403769–403844) in the V. parahaemolyticus
RIMD2210633 sequence, we identified the 24 kb VPaI-1
region (Figure 1A). The VPaI-1 region encompassed ORFs
VP0380 to VP0403 and encoded a phage-like integrase,
type I restriction endonuclease, haemagglutinin associ-
ated protein, transmembrane protein, transcriptional reg-
ulators as well as a number of hypothetical proteins.
Previously, we identified the homologous tRNA-Met
locus as a hotspot for insertion of novel DNA in V. vulnifi-
cus and V. cholerae isolates [22]. At this site in both species
a novel genomic island was inserted; in V. vulnificus
YJ016, a 43 kb V. vulnificus island-I (VVI-I) was present
and in V. cholerae O1 biotype El Tor pandemic strains, the
27 kb Vibrio seventh pandemic island-II (VSP-II) was
present (Figure 1A) [22,23]. In both V. vulnificus CMCP6
and V. fischeri ES114 the homologous tRNA-Met insertion
site contained no novel DNA. In V. vulnificus CMCP6 the
two homologous core chromosomal VPaI-1 flanking
genes were adjacent to one another, whereas in V. fischeri
ES114 only one flanking gene was identified (Figure 1A).
At the tmRNA site (genome location 674355–675321) in
V. parahaemolyticus RIMD2210633, the VPaI-2 region is
present, which encompassed ORFs VP0635 to VP0643
and encoded an integrase, outer membrane protein, a
resolvase, a ribonuclease H1 protein as well as a number
of hypothetical proteins (Figure 1B). At the homologous
tmRNA site in V. vulnificus YJ016 a 20 kb island region was
present and in V. vulnificus strain CMCP6 a 37 kb region
was present [24]. In V. cholerae, the 42 kb Vibrio Patho-
genicity Island-1 (VPI-1) region, which encodes the toxin
co-regulated pilus, was present [25]. In V. fischeri ES114 at
the homologous tmRNA site a 28 kb region was present,
which showed homology to prophage genes. At a tRNA-
Ser site (genome location 1121082–1121169) in V. para-
haemolyticus RIMD2210633 the 32 kb VPaI-3 region was
present (Figure 2A). The VPaI-3 region encompasses ORFs
VP1071 to VP1094 and encoded an integrase, a signal
transduction histidine kinase, a helicase, a methyl accept-
ing chemotaxis protein, an AcrBDF family protein as well
as numerous hypothetical proteins. In V. vulnificus at the
homologous insertion site, a 117 kb region was present
and in CMCP6 a 29 kb region with homology to the 117
kb region in YJ016 was present (Figure 2A) [24]. At the
homologous site in V. cholerae the 57 kb VPI-2 region,
which encoded neuraminidase and genes required for
sialic acid metabolism, was present [26,27]. In V. fischeri
ES114 at this site no horizontally acquired DNA was
present (Figure 2A). In V. parahaemolyticus
Table 1: Genomic Islands (Gis) identified in V. parahaemolyticus RIMD2210633 genome sequence.
GIs Location (bp)(ORFs) Directrepeat size SizeKb Int/Tnp tRNAsite %GC 1000X 6* % GF withlower 6*
VPaI-1 381054–403433 
(VP0380–VP0403)
45 24 Int tRNA-Met 42 69.1 97.8
VPaI-2 6660707–674355 
(VP0635–VP0643)
10 10 Int tmRNA 45 76.7 93.9
VPaI-3 1121252–1152668 
(VP1071–VP1094)
- 32 Int tRNA-Ser 42 53.1 98.8
VPaI-4 2240007–2256166 
(VP2131–VP2144)
30 17 Int tRNA-Ser 39 89.3 99.5
VPaI-5 3084846–3099979 
(VP2900–VP2910)
13 12 Int - 38 130.5 100
VPaI-6 1325821–1352643 
(VPA1253–VPA1270)
8 27 Int - 43 72.1 97.2
VPaI-7 1390967–1501509 
(VPA1312–VPA1398)
8 81 Tnp - 39 77.4 100
δ*-average dinucleotide relative abundance difference
Int/Tnp- Integrase/Transposase
GF-Genome FragmentsPage 3 of 19
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tion 2239837–2239927) the 17 kb VPaI-4 region was
present encompassing ORFs VP2131 to VP2144 (Figure
2B). The VPaI-4 region encoded an integrase, a putative
pore forming cytotoxin integrase, an M protein, an
ATPase, a histone deacetylase as well as a number of hypo-
thetical proteins. The M protein is a classical bacterial sur-
face expressed virulence factor and the cytotoxin integrase
may also be a potential virulence factor. At the homolo-
gous tRNA-Ser site in both V. vulnificus strains YJ016 and
CMCP6 a 7.5 kb region of unique DNA was present (Fig-
ure 2B). However, at the homologous sites in V. cholerae
N16961 and V. fischeri ES114 no novel DNA was present,
and in V. cholerae the core flanking island genes were adja-
cent to one another (Figure 2B). The 12 kb VPaI-5 region
encompassed ORFs VP2900 to VP2910 (Figure 3A). VPaI-
5 encoded in addition to two integrases, a number of
unknown and hypothetical proteins. The homologous
core chromosomal flanking genes of VPaI-5 in V. vulnifi-
cus strains YJ016 and CMCP6, V. cholerae N16961 and V.
fischeri ES114 were adjacent to one another indicating the
absence of novel DNA at this site (Figure 3A). The 27 kb
VPaI-6 region encompassed VPA1254 to VPA1270 and
encoded an integrase, 3, 4 dihydroxy-2-butanone-4 phos
(DHBP) synthase, two putative colicin proteins, a hydro-
lase and a number of hypothetical proteins. The homolo-
gous core chromosomal flanking genes of VPaI-6 in V.
vulnificus strains YJ016 and CMCP6, V. cholerae N16961
and V. fischeri ES114 were either dispersed on the genome
or were absent (Figure 3B). The 81 kb VPaI-7 region
encompassed VPA1312 to VPA1398 encoded a TTS sys-
tem previously described by Makino and colleagues [19].
Distribution of VPaI-1 among pre-1996 and post-1995 
isolates
Since the tRNA-Met site in V. cholerae isolates contained
DNA (VSP-II) unique to pandemic isolates, we decided to
examine this region further among V. parahaemolyticus iso-
lates [23,28]. To determine whether VPaI-1 is unique to
pandemic V. parahaemolyticus, we examined a collection
of 41 V. parahaemolyticus strains encompassing various
serotypes recovered from a range of geographic regions
over a 30 year period. The V. parahaemolyticus strains
examined included 10 serotype O3:K6 isolates recovered
between 1980 and 1995; 17 serotype O3:K6 isolates
recovered between 1996 and 1998; 13 isolates represent-
ing serotypes O1:KUT, O1:K25 (2 isolates), O2:K28,
O3:K4, O3:K53, O4:K8, O4:K11 (2 isolates), O4:K68 (3
isolates) and O8:K22, and 1 strain of undetermined sero-
type (Table 2). These 41 isolates were further character-
ized using the differences in toxRS nucleotide sequence
first described by Matsumoto and co-workers, which they
called a group specific PCR (GS-PCR) that has been
shown to differentiate post-1995 pandemic strains from
non-pandemic and pre-1996 isolates (Table 2) [6]. Of the
41 V. parahaemolyticus strains examined using GS-PCR, 25
strains gave a positive PCR band of the expected size and
16 V. parahaemolyticus isolates did not yield any PCR prod-
uct (Table 2). One toxRS-positive strain 1364 was previ-
ously shown by Wong and colleagues to belong to the old
O3:K6 group and in their analysis this strain gave no PCR
band with the same primer pair [15]. Our result suggests
that the isolate we examined was not the same 1364
strain. We sequenced the housekeeping gene malate dehy-
drogenase (mdh) from strain 1364 using a primer pair
designed from the sequenced strain RIMD2210633. The
mdh nucleotide sequence from strain 1364 differed by
only one nucleotide from the RIMD2210633 mdh
sequence indicating they are very closely related strains.
One additional strain gave anomalous results compared
to a previous study, where KE10464 was shown by Osawa
and colleagues to give positive PCR results with the toxRS
primer pair [29]. It appears that there may have been a
mix up in strain numbering in the distribution of these
strains.
A. Schematic representation of V. parahaemolyticus island-1 (VPaI-1) and the homolog us tRNA-Met inser on site in V. vulnificus strains YJ016 and CMCP6, V. cholerae N16961, and V. fisc ri ES114Figur  1
A. Schematic representation of V. parahaemolyticus 
island-1 (VPaI-1) and the homologous tRNA-Met 
insertion site in V. vulnificus strains YJ016 and 
CMCP6, V. cholerae N16961, and V. fischeri ES114. 
Block arrows represent annotated open reading frames 
(ORFs). Numbers above block arrows indicate ORF number 
on the sequenced genome strain. Black filled in ORFs repre-
sent core chromosomal genes. Open arrows represent 
genomic island ORFs. Shaded arrows represent integrase 
genes. Vertical arrows represent homologous tRNA-Met 
genes within each genome. Shaded blocks indicate homolo-
gous ORFs among the Vibrio species. B. Schematic represen-
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BMC Genomics 2006, 7:104 http://www.biomedcentral.com/1471-2164/7/104A total of 9 primer pairs were used to determine the distri-
bution of VPaI-1 among 41 V. parahaemolyticus natural
isolates (Table 3). Six primer pairs were designed within
the VPaI-1 region, two primer pairs encompassing each of
the VPaI-1 flanking core chromosomal genes, VP0379 and
VP0404, and a primer pair comprised of a forward primer
from VP0379 and a reverse primer designed from VP0404
(Table 3). Of the 41 V. parahaemolyticus strains examined
by PCR with 6 primer pairs encompassing the VPaI-1
region (VP0380 to VP0403), 24 strains gave positive PCR
bands of the expected sizes indicating the presence of
VPaI-1 in these strains (Figure 4A, Table 4). For example,
PCR assays with primer pair VP0388F/VP0392R on DNA
from the 41 V. parahaemolyticus isolates, gave an expected
size product of 2.3 kb with 24 strains (Figure 4A, lanes 2
to 25). The 24 PCR positive strains were all recovered
post-1995 and had a worldwide distribution (Table 4); 17
V. parahaemolyticus serotype O3:K6 strains, 1 serotype
O4:K11 strain recovered in Taiwan in 1999, 1 serotype
O1:KUT recovered in Bangladesh and 2 serotype O1:K25
strains recovered in Taiwan and Thailand in 1998 and
1999, 3 serotype O4:K68 strains recovered in 1998 and
1999 in Bangladesh, Singapore and Taiwan (Table 4).
These VPaI-1 positive isolates were the same set of isolates
that gave positive PCR products with the GS-PCR primer
pair (Table 2). All V. parahaemolyticus strains recovered
pre-1996 gave negative PCR results for the six primer pairs
encompassing VPaI-1 as well as five strains isolated in
Spain and Taiwan between 1998 and 2003 (Table 4). All
PCR negative results were confirmed by Southern hybrid-
isation analysis using DNA probes encompassing VP0388
to VP0392. Of the 17 VPaI-1 negative V. parahaemolyticus
isolates, 16 were negative for the GS-PCR assay, the excep-
tion being strain KE10462 (Table 4).
To determine whether in each of the VPaI-1-positve
strains the chromosomal insertion site was identical, a
primer pair was designed which comprised of a forward
primer within VP0379, the 5' core VPaI-1 flanking gene,
and a reverse primer within VP0380, the first gene within
the island. For all VPaI-1-positive isolates, a 2.3 kb PCR
product was obtained (Figure 4A). To confirm that the
VPaI-1 regions examined by PCR assays were contiguous
within each isolate, overlapping PCR was carried out
using three sets of primer pairs on VPaI-1-positive strains
only (Table 3). For example, a primer pair encompassing
VP0384 to VP0387 was used to amplify a 3 kb product
from all VPaI-1-positives isolates, indicating that this
region is contiguous with VP0382-VP0384 amongst these
isolates (Figure 4A).
As expected, positive PCR results with primer pairs mark-
ing 5' VP0379 and 3' VP0404 core chromosomal VPaI-1
flanking genes were obtained for all 41 V. parahaemolyticus
strains, indicating that these genes are present in all iso-
lates (Table 4). Thus, primer pair VP0379F/VP0379R and
VP0404F/VP0404R gave a 0.6 kb and 1.4 kb PCR product
with all 41 strains tested (Figure 4A). To determine
whether in VPaI-1-negative isolates these core chromo-
somal genes (VP0379 and VP0404) are adjacent to one
another, we carried out a PCR assay with a forward primer
(379F) designed from VP0379 and a reverse primer
(404R) designed from VP0404 (Figure 4B). We found that
among the 17 isolates that did not contain the VPaI-1
region, 15 strains gave a positive PCR band of 2.9 kb indi-
cating that in these strains VP0379 and VP0404 are adja-
cent to one another and the insertion site for VPaI-1 is
empty (Table 4, Figure 4B). Two VPaI-1 negative strains,
428/00 and 30824 recovered in Spain 1998 and 1999, did
not yield a PCR product with the primer pair 379F and
404R, which suggested that additional DNA may be
A and B. Schematic representation of V. parahaemolyticus isl -3 (VPaI-3) and VPaI-4, and the homologous insertion site among the 4 sequenced Vibrio speciesFigure 2
A and B. Schematic representation of V. parahaemo-
lyticus island-3 (VPaI-3) and VPaI-4, and the homolo-
gous insertion site among the 4 sequenced Vibrio 
species. Block arrows represent annotated ORFs. Black 
filled in ORFs represent core chromosomal flanking genes. 
Open and shaded arrows represent genomic island ORFs. 
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BMC Genomics 2006, 7:104 http://www.biomedcentral.com/1471-2164/7/104present in these strains at this region (Figure 4B). We per-
formed long range PCR on both of these isolates and
obtained a 7 kb product indicating that in these isolates 4
kb of novel DNA is present (Figure 4C). Further analysis
by Southern hybridisation using a DNA probe from the
379F/404R primer pair PCR product from strain KE9984
(VPaI-1 negative strain) showed the expected band sizes
from strain 428/00 and 30824. Hybridisation of EcoR1
digested RIMD2210633 DNA with the 379/404 probe
produced the expected size bands of 11.4 kb, 6.6 kb and 3
kb (Figure 5, lane 3). Hybridisation of EcoRI digested
KE9984 and KE9967 DNA (VPaI-1 negative strains) with
the 379/404 probe gave an expected 11.4 kb and 8 kb
bands indicating that in these strains this tRNA-Met site is
empty. Strains 30824 and 428/00 gave an approximately
11 kb and 13 kb size bands with the 379/404 DNA probe
indicating that in these strains a 4 kb fragment of DNA is
present between VP0379 and VP0404 (Figure 5).
Distribution of VPaI-4 among V. parahaemolyticus
To further examine the possible link between the acquisi-
tion of novel DNA and the emergence of pandemic iso-
lates, we investigated the presence of three additional
regions (VPaI-4, VPaI-5, and VPaI-6) among our collec-
tion of 41 V. parahaemolyticus isolates. For molecular anal-
yses of VPaI-4, 7 primer pairs designed from strain
RIMD2210633 encompassing the 17 kb region and the
core 5' and 3' VPaI-4 core chromosomal flanking genes
were used (Table 3). The 4 internal VPaI-4 primer pairs
gave PCR products of the expected size with DNA tem-
plate from each of 24 of the 41 isolates examined (Table
5). These were the same 24 isolates that were positive for
the presence of VPaI-1 (Table 4). For both the 5' and 3'
core chromosomal VPaI-4 flanking primer pairs the
expected size PCR products were obtained for all 41 iso-
lates examined indicating that they represent core ances-
tral genes (Table 5). A PCR assay based on a primer pair
binding to chromosomal regions flanking the VPaI-4
region was used to determine whether in VPaI-4-negative
strains the flanking genes are adjacent to one another. As
expected only the 17 VPaI-4-negative V. parahaemolyticus
isolates gave a 2.5 kb PCR product with the primer pair
designed from the 5' and 3' flanking genes (Table 5). No
PCR products were obtained with VPaI-4 positive strains
since the distance between the primer binding sites is too
large (Table 5). This result showed that in VpaI-4-negative
isolates the core chromosomal VPaI-4 flanking genes are
adjacent to one another.
To show that in each of the VPaI-4-positive strains that the
chromosomal insertion site was identical, a primer pair
was designed that comprised of a forward primer within
VPaI-4 gene VP2143 and a reverse primer within the 3'
core chromosomal flanking gene VP2145 (Table 3). For
all VPaI-4-positive isolates, an expected 3.3 kb PCR prod-
uct was obtained (Figure 6A). To confirm that the VPaI-4
regions examined by PCR assays were contiguous within
each isolate, overlapping PCR was carried out using an
additional three sets of primer pairs (Table 3). A primer
pair encompassing VP2135 to VP2137 was used to
amplify a 2.9 kb product from all VPaI-4-positives iso-
lates, indicating that this region is contiguous with
VP2137-VP2139 (Figure 6A). Identical results were
obtained with primer pairs encompassing VP2132 to
VP2135 and VP2139 to VP2142 showing that these
regions are contiguous. Thus it appears that in VPaI-4-pos-
itive isolates the structure and size of the island among the
isolates is similar.
A and B. Schematic representation of V. parahaemolyticus isl -5 (VPaI-5) and VPAI-6, nd the homologous insertion site among the 4 sequenced Vibrio speciesFigure 3
A and B. Schematic representation of V. parahaemo-
lyticus island-5 (VPaI-5) and VPAI-6, and the homolo-
gous insertion site among the 4 sequenced Vibrio 
species. Block arrows represent annotated ORFs. Black 
filled in ORFs represent core chromosomal flanking genes. 
Open arrows represent genomic island ORFs. Shaded blocks 
indicate homologous ORFs among the Vibrio species.
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BMC Genomics 2006, 7:104 http://www.biomedcentral.com/1471-2164/7/104Distribution of VPaI-5 among V. parahaemolyticus
Three primer pairs encompassing the 12 kb VPaI-5 region
were used to examine the 41 V. parahaemolyticus isolates
(Table 3). For all primer pairs, 24 isolates gave a PCR
product of the expected size, these were the same 24 iso-
lates that were positive for the presence of VPaI-1 and
VPaI-4 (Table 6). The 17 VPaI-5-negative isolates gave a
2.8 kb PCR product with a primer pair designed from the
5' and 3' core chromosomal VPaI-5 flanking genes
VP2898 and VP2912 respectively, indicating that these
genes are adjacent to one another and no novel DNA is
present in these isolates (Table 6).
By PCR assay we show that in each of the VPaI-5-positive
strains the insertion site of the island was identical, with a
forward primer within the 5' core chromosomal flanking
gene VP2898 and a reverse primer within the first gene of
VPaI-5 VP2900 (Table 3). From all VPaI-5-positive iso-
lates an expected 4 kb PCR product was obtained indicat-
ing that the island is inserted at the same site in all strains
tested (Figure 6B). To confirm that the VPaI-5 regions
examined by PCR assays were contiguous within each iso-
late, overlapping PCR was carried out using an additional
3 sets of primer pairs (Table 3). DNA from all VPaI-4-pos-
itives isolates by PCR assay amplified a 2.6 kb product
Table 2: Bacterial strains used in this study.
Strain Year Isolated Serovar Country of 
Isolation
Source GS-PCR tdh Reference
RIMD2210633 1996 O3:K6 Japan Human + + [16]
97 LPV 2 1997 O3:K6 Laos Human + + [7]
VP2 1998 O3:K6 Korea Human + + [7]
VP47 1998 O3:K6 Thailand Human + + [7]
VP208 1997 O3:K6 India Human + + [15]
VP81 1996 O3:K6 India Human + + [7]
NIIDK7 1998 O3:K6 Japan Human + + [29]
KE10457 1998 O3:K6 Japan Human + + [29]
KE10472 1998 O3:K6 Japan Human + + [29]
KE10484 1998 O3:K6 Japan Human + + [29]
KE10495 1996 O3:K6 Japan Human + + [29]
KE10527 1998 O3:K6 Japan Food + + [29]
MW2 1998 O3:K6 Peru Human + + This study
MW3 1998 O3:K6 Peru Human + + This study
MW4 1998 O3:K6 Peru Human + + This study
MW5 1998 O3:K6 Peru Human + + This study
MW6 1998 O3:K6 Peru Human + + This study
A6 1999 O1:K25 Thailand Human + + [15]
1362 1999 O4:K68 Taiwan Human + + [15]
AN- 5034 1998 O4:K68 Bangladesh Human + + [7]
A18 1998 O4:K68 Singapore Human + + [15]
1364 1999 O4:K11 Taiwan Human + + [15]
AN-16000 1998 O1:KUT Bangladesh Human + + [7]
1347 1998 O1:K25 Taiwan Human + + [15]
UCM V586 2003 O8:K22 Spain Mollusc - - [7]
KE10443 1995 O3:K6 Japan Human - - [29]
KE10464 1988 O3:K6 Japan Food - - [29]
AQ4235 1987 O3:K6 Thailand Human - - [15]
AQ4299 1987 O3:K6 Thailand Human - - [15]
KE10462 1986 O3:K6 Japan Food + - [29]
AQ4037 1985 O3:K6 Maldives Human - - [15]
KE10461 1982 O3:K6 Japan Environmental - - [29]
KE9967 1981 O3:K6 Japan Human - + [29]
KE9984 1981 O3:K6 Japan Human - - [29]
U-5474 1980 O3:K6 Bangladesh Human - + [15]
ATCC43996 1970 O3:K4 U.K Human - + [7]
UCM V553 2003 O3:K53 Spain Mollusc - - [7]
UCM V493 2002 O2:K28 Spain Sediment - - [7]
30824 1999 O4:K11 Spain Human - + [7]
428/00 1998 N/A Spain Human - + [7]
1324 1998 O4:K8 Taiwan Human - + [15]Page 7 of 19
(page number not for citation purposes)
BMC Genomics 2006, 7:104 http://www.biomedcentral.com/1471-2164/7/104with a primer pair encompassing VP2901 to VP2903 (Fig-
ure 6B). Identical results were obtained with primer pairs
encompassing VP2903 to VP2905 and VP2906 to VP2908
with DNA from VPaI-5-positive isolates as template for
PCR assays.
Distribution of VPaI-6 among V. parahaemolyticus
To determine the distribution of VPaI-6 (VPA1254 to
VPA1270) encoded on chromosome 2, we used 6 primer
pairs spanning the 27 kb region. Similar to the results for
VPaI-1, VPaI-4, and VPaI-5, the same set of 24 isolates
gave a PCR product of the expected size with each primer
pair (Table 7). A primer pair designed within VPA1251
and VPA1253, and a primer pair within VPA1271 all gave
a positive PCR product with all strains examined indicat-
ing that these genes represent core chromosomal flanking
genes (Table 7). The 17 VPaI-6-negative strains gave an
expected size PCR product of 0.8 kb with a primer pair
designed from the 5' and 3' flanking genes (VPA1253 and
VPA1271) indicating that these genes are adjacent to one
another in these strains (Table 7).
The insertion site of VPaI-6 among all isolates was exam-
ined by PCR assay with a forward primer within the 5' core
A. Schematic representation of VPaI-1 showing arrow heads representing primer pairs used in this studyFigur  4
A. Schematic representation of VPaI-1 showing arrow heads representing primer pairs used in this study. PCR 
analysis of the 41 V. parahaemolyticus strains is shown representing the results from 3 primer pairs. Lanes 1 and 44 represent 
size markers; lanes 2 to 42 contain strains analysed in the same order as in Table 2. For overlapping PCR primer pair analysis 
only VPaI-1-positive strains were examined, lanes 2 to 25 contain strains analysed in the same order as in Table 3. PCR primer 
pairs used are indicated under each agarose gel. B. Schematic representation of tRNA-Met site in VPaI-1-negative strains. 
Arrow heads represent primer pair used, which bind to the 5' and 3' core chromosomal flanking genes. PCR analysis of the 17 
VPaI-1-negative isolates (lanes 26 to 42) from section A. The band size is marked on the left side of the PCR image. An 
expected 2.9 kb product was obtained for all strains except 428/00 and 30824 (Lanes 16 and 17). Lane 1 contains marker. C. 
Schematic representation of tRNA-Met site in VPaI-1 negative strains 428/00 and 30824. Arrow heads represent primer pair 
used. Long Template Expand PCR on strains 428/00 and 30824 showed 4 kb of DNA at this insertion site. The band size is 
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Primers Anneal Temp Product size Primer sequences
VPaI-1
VP0379F-VP0379R 52.2 589nt Forward 5'-CAGTAATCAAAGTCGGAGC -3' Reverse 5'-ATAACTGCGAGAGGTGC -3'
VP0380F-VP0380R 50.7 1004nt Forward 5'-ATCTCTGGGATCAGTCAGG -3' Reverse 5'-GCGATAACGAGTCACTG -3'
VP0382F-VP0384R 50.4 1809nt Forward 5'-CGTATTCCATGAATGTCGAG -3' Reverse 5'-GCTCTGCGTAATGCTTC -
3'
VP0387F-VP0387R 51.9 1422nt Forward 5'-CCTAGATTTCAAAGGAAGTGCG-3' Reverse 5'-
GTCACGGATATGTTGTCTTG-3'
VP0388F-VP0392R 53.4 2256nt Forward 5'-GTTGGTCTTAATGCCCG -3' Reverse 5'-ACGTACTGTTCAAGCCGAC -3'
VP0395F-VP0398R 53.2 2393nt Forward 5'-TGTCCGCCAAAAACAGG -3' Reverse 5'-
GCTGAGATCATCGAAAGTTACG -3'
VP0401F-VP0402R 51 1171nt Forward 5'-GTCTTCTGTGAATGACTGC -3' Reverse 5'-TTAGCTTCTTCGTCACCCC 
-3'
VP0404F-VP0404R 52.1 1397nt Forward 5'-CATGGGTATCAAGGTAGTAG -3' Reverse 5'-TCTCCATTGAGATTGGC -
3'






50 2304nt Forward 5'-ATAACTGCGAGAGGTGC -3' Reverse 5'-GCGATAACGAGTCACTG -3'
VP0384R-
VP0387R




53 2035nt Forward 5'-ATTGGGGTTGGATGTCGTGG-3' Reverse 5'-
CGAACGTGTTCAATACTACG-3'
VPaI-4
VP2130F-VP2130R 52.3 1575nt Forward 5'-GCTTCGATGTTGATAGGC -3' Reverse 5'-GATGAGAGCAAGTTCTCG -3'
VP2131F-VP2133R 51.3 1785nt Forward 5'-CACGTATTTCCACTCCAG -3' Reverse 5'-CCCATACTTCACCATCTTTC -
3'
VP2135F-VP2135R 50.4 1653nt Forward 5'-GGTAAGAGTGAAGAGGTTCAG-3' Reverse 5'-
CCGACTGTAAATCTCATCG-3'
VP2137F-VP2139R 50.9 2914nt Forward 5'-TCGTGTGAAATGCGAAC -3' Reverse 5'-CGACGTAGACTTTTAGCC -3'
VP2143F-VP2143R 50.5 1354nt Forward 5'-GCAGTCGAACTTGAAGAC -3' Reverse 5'-ATGACCTCTCTGCATCC -3'
VP2145F-VP2145R 52 727nt Forward 3'-TATCCACCACCCACAAC-3' Reverse 3'-ATGTGCAAGCTGAGTGG-3'




VP2143F-VP2145R 49 3291nt Forward 5'-GCAGTCGAACTTGAAGAC -3' Reverse 3'-ATGTGCAAGCTGAGTGG-3'
VP2132F-VP2135R 50 2387nt Forward 5'-TCCCTCGTTTCTTGCTC-3' Reverse5'-CTTGTCACAATGATCTCCTG-3'
VP2135F-VP2137R 51 2900nt Forward 5'-GCTGGATTAGGACTTGATAC-3' Reverse5'-TACTAACCTCCCATCGG-3'
VP2140F-VP2142R 52 2562nt Forward 5'-GGCGTAATTTCTCAGATTCC-3' Reverse 5'-
GCTAAACGTGTTGCTGTTG-3'
VPaI-5
VP2900F-VP2900R 50.3 1377nt Forward 5'-GGGGAACCAGTTATAGG-3' Reverse 5'-ACCGTGAGACGCAGTATCAG -
3'
VP2905F-VP2905R 50.7 2035nt Forward 5'-CTGATGAGCAGTTTCCG -3' Reverse 5'-TCCATTGTTGTTGCAGG -3'
VP2908F-VP2908R 50.6 2313nt Forward 5'-GGCATGAAATCTTGCAG-3' Reverse 5'-CTCACATAGTTACATTGCGG
2898F-2912R 59.3 2800nt Forward 5'-CAGCCAAGACCACAAAC-3' Reverse 5'-AATCCCTAGCAGGTTGC-3'
Overlapping 
PCR primers
VP2898F-VP2900R 52 3988nt Forward 5'-CAGCCAAGACCACAAAC-3' Reverse 5'-ACCGTGAGACGCAGTATCAG -
3'
VP2901F-VP2903R 52 2577nt Forward 5'-AACGCCAAAGTTGCCTG -3' Reverse 5'-
CCGTAAGTAAAGGTTCATCTGC -3'
VP2903F-VP2905R 53 2330nt Forward 5'-TCACGTTTGAAGCTCGC -3' Reverse 5'-GTGCCGTATTCTCTTTGTAG -
3'





51.3 1169nt Forward 5'-TCGTAAACACTGCCAGC -3' Reverse 5'-CTAGCAACGGTGATAGC -3'Page 9 of 19
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VPA1255R




51.5 2033nt Forward 5'-GGCTTTAGGTACTGCTACC -3' Reverse 5'-GGAATCACGTTCTCTGG -3'
VPA1262F-
VPA1262R




53 2144nt Forward 5'-CTACGAAGGTAATCTCGC -3' Reverse 5'-TACCCGCATCAGCTAAC -3'
VPA1266F-
VPA1266R
52.5 1879nt Forward 5'-ATCCCTTATCGCTCGAC-3' Reverse 5'-CGGATTGTGTTATCTCG-3'
VPA1270F-
VPA1270R
53.2 2225nt Forward 5'-TGGAACACGCATCCTAC-3' Reverse 5'-ACGACTGAGTTGCATCGAG-3'
VPA1271F-
VPA1271R
51.9 432nt Forward 5'-CAGCACACTTTTACTGGC -3' Reverse 5'-TGCATCGAACTAACCGC -3'





48 4590nt Forward 5'-TCGTAAACACTGCCAGC -3' Reverse 5'-TGATGAAGCGATATGCC -3'
VPA1256F-
VPA1259R








53 2885nt Forward 5'-CGAACCTTAAATGGACG -3' Reverse 5'-GACTAATGGCAAGTGGG -3'
Inverse PCR 
primers
VP0401F-VP0380R 49 4596nt Forward 5'-GTCTTCTGTGAATGACTGC -3' Reverse 5'-GCGATAACGAGTCACTG -3'













45 651nt Forward 5'-TAATGAGGTAGAAACA-3' Reverse 5'-ACGTAACGGGCCTACA-3'
VP0325F-VP0325R 54 901nt Forward 5'-TGAAAGTAGCCGTTATTGG -3' Reverse 5'-
CCATTTAGCGTTTCTAGCATTC-3'
Table 3: Primer Pairs used in this study. (Continued)Page 10 of 19
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primer within the first gene of VPaI-6, VPA1255 (Table 3).
For DNA from all VPaI-6-positive isolates an expected 4.6
kb PCR product was obtained indicating that the island is
inserted at the same site in all strains tested (Figure 6C).
To confirm that the VPaI-6 regions examined by PCR
assays were contiguous within each isolate, overlapping
PCR was carried out using additional sets of primer pairs
(Table 3). All VPaI-6-positive isolates by PCR assays,
amplified a 4.6 kb PCR product with a primer pair encom-
passing VPA1251 to VPA1255, a 2 kb PCR product with
primer pair VPA1256F/VPA1259R, a 1.4 kb product with
a primer pair encompassing VPA1259 to VPA1261, and a
2.9 PCR product with VPA1264F/VPA1268R (Figure 6C).
Table 4: Occurrence and distribution of Group Specific and VPaI-1 genesamong V. parahaemolyticus isolates.
Strains Serovar GS-PCR VP 0379 VP 0380 VP 
0382–84










O3:K6 + + + + + + + + + -
97 LPV 2 O3:K6 + + + + + + + + + -
VP2 O3:K6 + + + + + + + + + -
VP47 O3:K6 + + + + + + + + + -
VP208 O3:K6 + + + + + + + + + -
VP81 O3:K6 + + + + + + + + + -
NIIDK7 O3:K6 + + + + + + + + + -
KE10457 O3:K6 + + + + + + + + + -
KE10472 O3:K6 + + + + + + + + + -
KE10484 O3:K6 + + + + + + + + + -
KE10495 O3:K6 + + + + + + + + + -
KE10527 O3:K6 + + + + + + + + + -
MW2 O3:K6 + + + + + + + + + -
MW3 O3:K6 + + + + + + + + + -
MW4 O3:K6 + + + + + + + + + -
MW5 O3:K6 + + + + + + + + + -
MW6 O3:K6 + + + + + + + + + -
A6 O1:K25 + + + + + + + + + -
1362 O4:K68 + + + + + + + + + -
AN-5034 O4:K68 + + + + + + + + + -
A18 O4:K68 + + + + + + + + + -
1364 O4:K11 + + + + + + + + + -
AN-
16000
O1:KUT + + + + + + + + + -
1347 O1:K25 + + + + + + + + + -
UCM 
V586
O8:K22 - + - - - - - - + +
KE10443 O3:K6 - + - - - - - - + +
KE10464 O3:K6 - + - - - - - - + +
AQ4235 O3:K6 - + - - - - - - + +
AQ4299 O3:K6 - + - - - - - - + +
KE10462 O3:K6 + + - - - - - - + +
AQ4037 O3:K6 - + - - - - - - + +
KE10461 O3:K6 - + - - - - - - + +
KE9967 O3:K6 - + - - - - - - + +
KE9984 O3:K6 - + - - - - - - + +
U-5474 O3:K6 - + - - - - - - + +
ATCC43
996
O3:K4 - + - - - - - - + +
UCM 
V553
O3:K53 - + - - - - - - + +
UCM 
V495
O2:K28 - + - - - - - - + +
30824 O4:K11 - + - - - - - - + -
428/00 N/A - + - - - - - - + -
1324 O4:K8 - + - - - - - - + +Page 11 of 19
(page number not for citation purposes)
BMC Genomics 2006, 7:104 http://www.biomedcentral.com/1471-2164/7/104Similar to VPaI-1, VPaI-4 and VPaI-5, it appears that in
VPaI-6-positive isolates, the island region has a similar
structure and size among all the isolates examined.
Investigation of excision of VPaI-1, VPaI-4, VPaI-5 and 
VPaI-6
The integrase (int) genes of VPaI-1 and VPaI-4 exhibit
homology to the int genes of coliphage P4 and bacteri-
ophage phi CTX, respectively. The int genes of VPaI-5 and
VPaI-6 show significant identities with other bacteri-
ophages. In addition, VPaI-1, VPaI-4, VPaI-5 and VPaI-6
are flanked by direct repeats, which could be equivalent to
the left and right attachment sites (attL and attR) that
result from the integration of phage DNA. Therefore, it is
possible that VPaI-1, VPaI-4, VPaI-5 and VPaI-6 may
excise from the V. parahaemolyticus genome similar to E.
coli PAIs, which have similar features, and form circular
intermediates via site specific recombination between the
direct repeats [30]. To determine the stability and poten-
tial mobility of VPaI-1, VPaI-4, VPaI-5, and VPaI-6, an
inverse PCR assay was carried out to test for the presence
of circular intermediates that result from excision of
island regions (Figure 7). Total DNA was extracted from
overnight cultures treated with and without mitomycin C
(induces excision). PCR was carried out using a primer
pair oriented towards the 5' and 3' island chromosomal
flanking genes (Figure 7). A PCR product can only be
amplified if the island regions have excised and formed
circular intermediates with the primer binding sites ori-
ented towards one another (Figure 7). Circular intermedi-
ates could not be detected under the conditions examined
in this study for any of the 4 island regions tested. The
deletion rate of these islands maybe very low and our PCR
assay may not have been sensitive enough.
Conclusion
In this study, we identified 7 regions named VPaI-1 to
VPaI-7, which had all the features of genomic islands that
is aberrant base composition compared to the entire
genome, the presence of a phage-like integrase, insertion
adjacent to tRNA genes and variable presence among
strains. A number of the VPaI regions (VPaI-4 and VPaI-6)
encoded putative virulence genes (M protein, hydrolases,
cytotoxin integrase, colicins) and therefore these regions
may represent potential pathogenicity islands. VPaI-1
encoded a type 1 restriction modification gene cluster,
which could potentially be involved in protecting the bac-
terium from viral infections (Virus resistance island).
However, all the VPaI regions encoded a large proportion
of hypothetical and unknown proteins. We examined the
24 kb VPaI-1 region among a range of pandemic and non-
pandemic V. parahaemolyticus isolates recovered over the
past 33 years. We determined that VPaI-1 was unique to
the pandemic group of V. parahaemolyticus strains isolated
after 1995. Further analysis of 3 additional regions, VPaI-
4, VPaI-5, and VPaI-6 showed that these too were unique
to the pandemic clone, indicating that the acquisition of
novel DNA by horizontal gene transfer has played an
important role in the emergence of these strains. The 12
kb VPaI-5 region encompassing VP2900 to VP2910
encodes ORF VP2905, which was previously shown to be
associated with the pandemic group of V. parahaemolyticus
isolates [31]. The VPaI-5 region was previously noted by
Okura and co-workers to encode a phage-like protein and
may therefore encode a phage [14]. Previous studies
examining the presence of strain specific DNA among
pathogenic V. cholerae isolates have shown that the acqui-
sition of DNA encoding virulence genes has played a cru-
cial role in the emergence of pandemic isolates of this
species [22,25,27,28,32]. The emergence of a novel epi-
demic V. cholerae O139 serogroup in 1992 was shown to
have resulted from the horizontal transfer of the O139
gene cluster into an O1 serogroup strain as well as the
acquisition of a capsule polysaccharide and an integrative
conjugative element [33-37]. The insertion of 4 of our
VPaI regions adjacent to tRNA genes has previously been
described for a number of GIs in Gram-negative bacteria
[38-40]. More recently it has been noted that there is a
bias in the integration of GIs into specific tRNA loci
[41,42]. As the VPaI regions described in this study are
examined further their role in the emergence of a pan-
demic clone will be elucidated. The recent discovery that
V. cholerae isolates are naturally competent in the presence
of chitin, an abundant substrate in the aquatic environ-
ment, may indicate a possible mechanism of DNA acqui-
sition among the Vibrionaceae [43].
Methods
Genome sequences
Complete nucleotide sequence and annotation was
retrieved and downloaded from NCBI ftp site for V. para-
haemolyticus RIMD2210633 (NC_004603, NC_004605)
[19,44].
Identification of genomic islands (GIs)
Several criteria were used in this study to identify GIs
within the sequenced strain RIMD2210633. Firstly, the
complete genome sequence of RIMD2210633 was exam-
ined for regions of sequence composition bias such as
aberrant G+C percentage compared to the entire chromo-
some. Regions of greater than 10 kb with a G+C content
that differed from the host genome were then examined
for the presence of integrase and transposase genes. The
regions encoding a prophage (VP1549 to VP1589) and a
superintegron (VP1765 to VP1866) were not examined
further. Seven candidate GI regions were analysed for
compositional bias of dinucleotide frequency. The dinu-
cleotide frequency analysis calculates the genomic dissim-
ilarity values δ* (the average dinucleotide relative
abundance difference) between GI sequences and the V.Page 12 of 19
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web based application, deltarho-web [20,21,45].
The dinucleotide frequency analysis shows that each
genome has a typical dinucleotide frequency (called the
genome signature ρ*) and that related species have a sim-
ilar genome signature [46,47]. Van Passel's method also
calculates the plot position (in %) of the GI sequence in
the δ*, compared to fragment number plot of the com-
plete genome divided in non-overlapping fragments of
equal size as the GI sequence, since the length of the GI
sequence is important in calculating the relevance of the
value of δ* [20,48]. Putative GI regions that fulfilled the
criteria of aberrant G+C and dinucleotide frequency were
then examined for the presence of insertion elements,
flanking direct repeats, and proximity of tRNA. The 7 GI
regions identified in V. parahaemolyticus strain
RIMD2210633 by the above criteria were further analysed
for sequence similarities using the BLAST algorithm to
determine whether the ORFs present in each island are
found among the other sequenced Vibrio genomes, V.
cholerae N16961, V. vulnificus YJ016 and CMCP6, and V.
fischeri ES114.
Bacterial strains
A total of 41 V. parahaemolyticus isolates were used in this
study (Table 2). The source of the 41 V. parahaemolyticus
isolates was temporally (1970 to 2003) and geographi-
cally (Asia, Europe and South America) widespread and
encompassed 10 different serotypes (Table 2). V. para-
haemolyticus strains were grown in Luria-Bertani (LB)
broth containing 3% NaCl. Stock cultures were stored at -
80°C in LB broth containing 30% glycerol.
Molecular analysis
Of the 7 regions identified by bioinformatic analyses, we
examined 4 regions in detail to determine their distribu-
tion among a collection of V. parahaemolyticus natural iso-
lates. For polymerase chain reaction (PCR) assays, total
DNA was extracted from overnight cultures in 3% NaCl
LB broth using G-nome DNA isolation kit (Bio101, USA).
To determine the presence of VPaI-1, for example, PCR
assays using 6 primer pairs designed from ORFs VP0380
to VP0403 of the sequenced RIMD2210633 genome were
used (Table 3, Figure 4A). In addition, primer pairs
VP379F/VP379R and VP404F/VP404R were designed to
amplify the gene VP0379, which is immediately 5' of
VP0380 and the gene VP0404, which is immediately 3' of
the tRNA-Met gene, the insertion site of VPaI-1. To exam-
ine isolates that did not contain the VPaI-1 region, a single
primer pair (379F/404R) consisting of a forward primer
379F and a reverse primer 404R was also used in this
study to determine whether VP0379 and VP0404 are
directly adjacent to one another in these VPaI-1 negative
strains (Table 3, Figure 4B). The 41 V. parahaemolyticus
strains were also examined with the GS-PCR primer pair
that specifically amplifies a 651 bp PCR product from new
O3:K6 and related pandemic isolates [6,12-14]. All PCR
reactions were performed in volumes of 25 µl containing
40 ng DNA, 10 pmol primer and 1 U Taq polymerase with
amplification conditions of 96°C for 3 min, followed by
30 cycles of 94°C for 30 sec, 45–60°C (depending on
primer pair) for 30 sec and 72°C for 1–4 min (depending
on expected PCR product size) and 72°C for 10 minutes.
The sequenced V. parahaemolyticus strain RIMD2210633,
which contains the VPaI-1 region was used as a positive
PCR control. Long range PCR reactions were performed
with Elongase ® Enzyme Mix (Invitrogen, Carlsbad, CA,
USA). The thermal profile for the long-range PCR amplifi-
cation included an initial pre-amplification denaturation
cycle of 94°C for 30 s, followed by 33 cycles of 94°C for
30 s, 64°C for 30 s and 68°C for 20 minutes. The primer
pairs used to investigate the presence of VPaI-4, VPaI-5
and VPaI-6 among the collection of V. parahaemolyticus
isolates are listed in Table 3. For all island-positive strains,
Southern hybridisation analysis of VPaI-1 negative strains 428/00 and 30824Figur  5
Southern hybridisation analysis of VPaI-1 negative 
strains 428/00 and 30824. PaI-1-negative strains KE9984 
and KE9967, VPaI-1-positive strain RIMD2210633 and VPaI-
1-negative strains 30824 and 428/00. Genomic DNA was 
restricted using EcoRI and the probe used was constructed 
from the PCR amplification using primer pair 379F and 404R 
with strain KE9984 as template. The expected 8 Kb and 11.4 
kb band sizes in the VPaI-1 negative strains KE9984 and 
KE9967 are shown (Lane 1–2). The VPaI-1 positive 
RIMD2210633 gave the expected 11.4 Kb, 6.6 Kb and 3.1 Kb 
band sizes (Lane 3). The VPaI-1 negative strains 30824 and 
428/00 with novel DNA inserted gave the expected band 
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tional PCR primer pairs per island to confirm that each
island region was located at the same insertion site and
that the structure of each island is similar amongst all the
strains examined (Table 3). Southern hybridisation anal-
ysis was performed on all VPaI-1 negative strains to con-
firm PCR negative results using a probe generated from
the PCR product derived from primer pair VP0388F/
VP0392 using reference strain RIMD2210633 as template.
DNA from each VPaI-1 negative strain was digested with
the restriction enzyme EcoRI (Roche Molecular Biochemi-
cals) and the fragments were separated by electrophoresis
in 0.6% TAE agarose. DNA fragments were transferred to
nylon membrane by a posiblotter (Stratagene). Probe
DNAs were labelled using the ECL direct nucleic acid
labelling system (Amersham Pharmacia Biotech) and pos-
itive hybridization was detected by the ECL chemilumi-
nescent substrate. Southern analyses were also preformed
on VPaI-4, VPaI-5 and VPaI-6 negative strains using a
probe generated from each of these island regions in
RIMD2210633. Nucleotide sequence analysis of the mdh
locus was preformed using a primer pair designed from
VP0325.
Table 5: Distribution of VPaI-4 region (ORFs VP2131 to VP2144) among V. parahaemolyticus natural isolates.
Strain Serovar VP2130 VP2131–33 VP2135 VP2137–39 VP2143 VP2145 2130–2145
RIMD 
2210633
O3:K6 + + + + + + -
97 LPV 2 O3:K6 + + + + + + -
VP2 O3:K6 + + + + + + -
VP47 O3:K6 + + + + + + -
VP208 O3:K6 + + + + + + -
VP81 O3:K6 + + + + + + -
NIIDK7 O3:K6 + + + + + + -
KE10457 O3:K6 + + + + + + -
KE10472 O3:K6 + + + + + + -
KE10484 O3:K6 + + + + + + -
KE10495 O3:K6 + + + + + + -
KE10527 O3:K6 + + + + + + -
MW2 O3:K6 + + + + + + -
MW3 O3:K6 + + + + + + -
MW4 O3:K6 + + + + + + -
MW5 O3:K6 + + + + + + -
MW6 O3:K6 + + + + + + -
A6 O1:K25 + + + + + + -
1362 O4:K68 + + + + + + -
AN-5034 O4:K68 + + + + + + -
A18 O4:K68 + + + + + + -
1364 O4:K11 + + + + + + -
AN-16000 O1:KUT + + + + + + -
1347 O1:K25 + + + + + + -
UCM V586 O8:K22 + - - - - + +
KE10443 O3:K6 + - - - - + +
KE10464 O3:K6 + - - - - + +
AQ4235 O3:K6 + - - - - + +
AQ4299 O3:K6 + - - - - + +
KE10462 O3:K6 + - - - - + -
AQ4037 O3:K6 + - - - - + +
KE10461 O3:K6 + - - - - + +
KE9967 O3:K6 + - - - - + +
KE9984 O3:K6 + - - - - + +
U-5474 O3:K6 + - - - - + +
ATCC43996 O3:K4 + - - - - + +
UCM V553 O3:K53 + - - - - + +
UCM V493 O2:K28 + - - - - + +
30824 O4:K11 + - - - - + +
428/00 N/A + - - - - + +
1324 O4:K8 + - - - - + +Page 14 of 19
(page number not for citation purposes)
BMC Genomics 2006, 7:104 http://www.biomedcentral.com/1471-2164/7/104Detection of excision of VPaI-1, VPaI-4, VPaI-5 and VPaI-6
An inverse PCR assay was carried out to test for the pres-
ence of circular intermediates that result from excision of
island regions. Five VPaI-positive and one VPaI-negative
V. parahemolyticus strains were cultured in LB 3% NaCl
broth. The broth was inoculated from single colonies
taken from overnight plate cultures and incubated over-
night on an orbital shaker at 30°C. The culture was
induced to the lytic cycle by the addition of 40 ngml-1
mitomycin C (Sigma-Aldrich). Induced cultures were fur-
ther incubated for 8–10 h on an orbital shaker at 30°C.
Cultures were centrifuged at 5000 g for 10 min to pellet
bacterial cells and the supernatant fluids were filtered
through 0·45µm membranes (Millipore). Aliquots of 2 µl
were subsequently used as template for inverse PCR.
Primer pairs oriented towards the 5' and 3' island chromo-
somal flanking genes were used to screen the filtrate
(Table 3). A PCR product can only be amplified if the
island regions have excised and formed circular interme-
diates with the primer binding sites oriented towards one
another.
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